Building the path to 3D-printed organs, Cellbricks raises €10M for biofabricated tissue implants

Berlin-founded biotech startup Cellbricks Therapeutics has raised €10 million to advance its goal of 3D-printed organs, beginning with biofabricated human tissue implants. If successful, Cellbricks is not just building better implants — it is laying the groundwork for manufacturing living human organs. The financing includes a €7 million seed round and more than €3 million in additional non-dilutive funding currently under negotiation. For patients with severe soft tissue loss, complex…